These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Inhibition of alpha-synuclein fibrillization by dopamine analogs via reaction with the amino groups of alpha-synuclein. Implication for dopaminergic neurodegeneration. Li HT; Lin DH; Luo XY; Zhang F; Ji LN; Du HN; Song GQ; Hu J; Zhou JW; Hu HY FEBS J; 2005 Jul; 272(14):3661-72. PubMed ID: 16008565 [TBL] [Abstract][Full Text] [Related]
13. Dopamine promotes alpha-synuclein aggregation into SDS-resistant soluble oligomers via a distinct folding pathway. Cappai R; Leck SL; Tew DJ; Williamson NA; Smith DP; Galatis D; Sharples RA; Curtain CC; Ali FE; Cherny RA; Culvenor JG; Bottomley SP; Masters CL; Barnham KJ; Hill AF FASEB J; 2005 Aug; 19(10):1377-9. PubMed ID: 15946991 [TBL] [Abstract][Full Text] [Related]
14. Alpha-synuclein oligomers and fibrils originate in two distinct conformer pools: a small angle X-ray scattering and ensemble optimisation modelling study. Curtain CC; Kirby NM; Mertens HD; Barnham KJ; Knott RB; Masters CL; Cappai R; Rekas A; Kenche VB; Ryan T Mol Biosyst; 2015 Jan; 11(1):190-6. PubMed ID: 25352253 [TBL] [Abstract][Full Text] [Related]
15. High stability and cooperative unfolding of α-synuclein oligomers. Paslawski W; Andreasen M; Nielsen SB; Lorenzen N; Thomsen K; Kaspersen JD; Pedersen JS; Otzen DE Biochemistry; 2014 Oct; 53(39):6252-63. PubMed ID: 25216651 [TBL] [Abstract][Full Text] [Related]
16. Parkinson's disease and alpha synuclein: is Parkinson's disease a prion-like disorder? Olanow CW; Brundin P Mov Disord; 2013 Jan; 28(1):31-40. PubMed ID: 23390095 [TBL] [Abstract][Full Text] [Related]
17. Binding of Dopamine to Alpha-Synuclein is Mediated by Specific Conformational States. Illes-Toth E; Dalton CF; Smith DP J Am Soc Mass Spectrom; 2013 Sep; 24(9):1346-54. PubMed ID: 23817832 [TBL] [Abstract][Full Text] [Related]
18. Alpha-Synuclein Fibrils Interact with Dopamine Reducing its Cytotoxicity on PC12 Cells. Khalife M; Morshedi D; Aliakbari F; Tayaranian Marvian A; Mohammad Beigi H; Azimzadeh Jamalkandi S; Pan-Montojo F Protein J; 2015 Aug; 34(4):291-303. PubMed ID: 26250981 [TBL] [Abstract][Full Text] [Related]
19. Altered ion channel formation by the Parkinson's-disease-linked E46K mutant of alpha-synuclein is corrected by GM3 but not by GM1 gangliosides. Di Pasquale E; Fantini J; Chahinian H; Maresca M; Taïeb N; Yahi N J Mol Biol; 2010 Mar; 397(1):202-18. PubMed ID: 20114052 [TBL] [Abstract][Full Text] [Related]
20. alpha -Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease. Lo Bianco C; Ridet JL; Schneider BL; Deglon N; Aebischer P Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10813-8. PubMed ID: 12122208 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]